Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
292.55+9.05 (+3.19%)
At close: 04:00PM EDT
291.40 -1.15 (-0.39%)
After hours: 07:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close283.50
Open286.26
Bid291.49 x 800
Ask292.90 x 1000
Day's Range280.40 - 293.09
52 Week Range176.36 - 293.17
Volume4,268,979
Avg. Volume1,772,575
Market Cap74.821B
Beta (5Y Monthly)0.55
PE Ratio (TTM)30.88
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
56% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for VRTX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Vertex Pharmaceuticals Incorpor
    Technical Assessment: Bearish in the Intermediate-TermLast week was (yet again) ugly for stocks, and the S&P 500 has now been down in 10 of the past 11 weeks (aka since the last week in March). The current move lower is much steeper than the decline from January to March 14. A steep decline leads to a high level of panic. But the faster prices fall, the sooner stocks can find an intermediate-term bottom. Both breadth and sentiment have been much worse during the current move lower than they were during the move off the highs earlier in the year.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
Advertisement
Advertisement